Clinical trial
Randomized, Multicentre, Phase II Study Evaluating the Interest of Imatinib Treatment Maintenance or Interruption After at Least 10 Years of Treatment in Patients With Locally Advanced/Metastatic Gastrointestinal Stromal Tumors (GISTs)
NCT05009927 is registered in ClinicalTrials.gov with Centre Leon Berard as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized, Multicentre, Phase II Study Evaluating the Interest of Imatinib Treatment Maintenance or Interruption After at Least 10 Years of Treatment in Patients With Locally Advanced/Metastatic Gastrointestinal Stromal Tumors (GISTs)
- Lead sponsor
- Centre Leon Berard
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- January 3, 2022
- Completion date
- January 31, 2027
- Enrollment
- 50 (estimated)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.
advanced gastrointestinal stromal tumor (gist), c-kit mutation, metastatic gastrointestinal stromal tumor (gist)